- Home
- IBCP vs CRMD Comparison
IBCP vs CRMD Comparison
Compare IBCP & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IBCP | CRMD |
|---|---|---|
| Founded | 1864 | 2006 |
| Country | United States | United States |
| Employees | 270 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 743.3M | 695.9M |
| IPO Year | 2010 | 2009 |
Fundamental Metrics
Financial Performance| Metric | IBCP | CRMD |
|---|---|---|
| Price | $37.64 | $7.87 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $37.00 | $14.83 |
| AVG Volume (30 Days) | 194.4K | ★ 1.2M |
| Earning Date | 04-23-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.35% | N/A |
| EPS Growth | 3.48 | ★ 780.00 |
| EPS | ★ 0.81 | 0.43 |
| Revenue | $32,075,000.00 | ★ $311,709,000.00 |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | $8.98 | N/A |
| P/E Ratio | $45.25 | ★ $18.72 |
| Revenue Growth | 0.30 | ★ 617.03 |
| 52 Week Low | $29.63 | $6.13 |
| 52 Week High | $37.75 | $14.96 |
Technical Indicators
Market Signals| Indicator | IBCP | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 62.24 | 42.72 |
| Support Level | $32.41 | $7.50 |
| Resistance Level | N/A | $9.02 |
| Average True Range (ATR) | 0.92 | 0.34 |
| MACD | 0.04 | -0.07 |
| Stochastic Oscillator | 89.32 | 13.57 |
Price Performance
Historical ComparisonAbout IBCP Independent Bank Corporation
Independent Bank Corp. operates as a commercial bank. It offers a broad range of banking services to individuals and businesses, including checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending, and safe deposit box services. It also provides internet and mobile banking capabilities to its customers. The firm's principal markets are the rural and suburban communities across Lower Michigan. The firm generates the majority of its revenue from Interest and fees on loans.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.